Please register to continue your trial period!
meRfi-GM provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.
Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.
Start your free trial and transform your understanding of the gut microbiota today!
Inflammatory Bowel Disease (IBD) affects more than 6 million people worldwide and constitutes not only a debilitating disease for the patients, but also a significant factor for society due to costs for health care and reduced working capacity.
Key factors for Inflammatory Bowel Disease (IBD) are similar worldwide. However, there are genetic, environmental, and microbial differences. These differences influence disease risk and disease progression. They also affect treatment responses. This aspect is often ignored in research.
Inflammatory bowel diseases (IBDs), including ulcerative colitis and [Crohn’s disease,](brain://zkmYnQfym06UbW5L9wiuww/C…